Literature DB >> 30181867

Epidemiology and risk factors for bipolar disorder.

Tobias A Rowland1, Steven Marwaha2.   

Abstract

Bipolar disorder is a multifactorial illness with uncertain aetiology. Knowledge of potential risk factors enables clinicians to identify patients who are more likely to develop bipolar disorder, which directs further investigation, follow up and caution when prescribing. Ideally, identifying directly causative factors for bipolar disorder would enable intervention on an individual or population level to prevent the development of the illness, and improve outcomes through earlier treatment. This article reviews the epidemiology of bipolar disorder, along with putative demographic, genetic and environmental risk factors, while assessing the strength of these associations and to what extent they might be said to be 'causative'. While numerous genetic and environmental risk factors have been identified, the attributable risk of individual factors is often small, and most are not specific to bipolar disorder but are associated with several mental illnesses. Therefore, while some genetic and environmental factors have strong evidence supporting their association with bipolar disorder, fewer have sufficient evidence to establish causality. There is increasing interest in the role of specific gene-environment interactions, as well as the mechanisms by which risk factors interact to lead to bipolar disorder.

Entities:  

Keywords:  bipolar disorder; epidemiology; risk factors

Year:  2018        PMID: 30181867      PMCID: PMC6116765          DOI: 10.1177/2045125318769235

Source DB:  PubMed          Journal:  Ther Adv Psychopharmacol        ISSN: 2045-1253


  138 in total

1.  Cannabis use and expression of mania in the general population.

Authors:  Cécile Henquet; Lydia Krabbendam; Ron de Graaf; Margreet ten Have; Jim van Os
Journal:  J Affect Disord       Date:  2006-06-21       Impact factor: 4.839

Review 2.  Genetics of bipolar disorder: successful start to a long journey.

Authors:  Nick Craddock; Pamela Sklar
Journal:  Trends Genet       Date:  2009-01-12       Impact factor: 11.639

3.  Evidence that the urban environment specifically impacts on the psychotic but not the affective dimension of bipolar disorder.

Authors:  Nil Kaymaz; Lydia Krabbendam; Ron de Graaf; Willem Nolen; Margreet Ten Have; Jim van Os
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2006-07-03       Impact factor: 4.328

Review 4.  Bipolar disorder prevalence: a systematic review and meta-analysis of the literature.

Authors:  Adauto S Clemente; Breno S Diniz; Rodrigo Nicolato; Flavio P Kapczinski; Jair C Soares; Josélia O Firmo; Érico Castro-Costa
Journal:  Braz J Psychiatry       Date:  2015-05-01       Impact factor: 2.697

5.  Impaired functioning in euthymic patients with bipolar disorder--HSV-1 as a predictor.

Authors:  Sonja I Gerber; Ute J Krienke; Nane-Christine Biedermann; Heinz Grunze; Robert H Yolken; Sandra Dittmann; Jens M Langosch
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2011-09-14       Impact factor: 5.067

6.  Familiality of the puerperal trigger in bipolar disorder: results of a family study.

Authors:  I Jones; N Craddock
Journal:  Am J Psychiatry       Date:  2001-06       Impact factor: 18.112

7.  Affective instability, childhood trauma and major affective disorders.

Authors:  S Marwaha; K Gordon-Smith; M Broome; P M Briley; A Perry; L Forty; N Craddock; I Jones; L Jones
Journal:  J Affect Disord       Date:  2015-11-17       Impact factor: 4.839

8.  Stressful life events and the onset of chronic diseases among Australian adults: findings from a longitudinal survey.

Authors:  Andre M N Renzaho; Brendan Houng; John Oldroyd; Jan M Nicholson; Fabrizio D'Esposito; Brian Oldenburg
Journal:  Eur J Public Health       Date:  2013-02-08       Impact factor: 3.367

Review 9.  A systematic review of calcium channel antagonists in bipolar disorder and some considerations for their future development.

Authors:  A Cipriani; K Saunders; M-J Attenburrow; J Stefaniak; P Panchal; S Stockton; T A Lane; E M Tunbridge; J R Geddes; P J Harrison
Journal:  Mol Psychiatry       Date:  2016-05-31       Impact factor: 15.992

10.  Toxoplasma gondii exposure may modulate the influence of TLR2 genetic variation on bipolar disorder: a gene-environment interaction study.

Authors:  José Oliveira; Rémi Kazma; Edith Le Floch; Meriem Bennabi; Nora Hamdani; Djaouida Bengoufa; Mehdi Dahoun; Céline Manier; Frank Bellivier; Rajagopal Krishnamoorthy; Jean-François Deleuze; Robert Yolken; Marion Leboyer; Ryad Tamouza
Journal:  Int J Bipolar Disord       Date:  2016-05-20
View more
  47 in total

1.  Diagnosis and Treatment of Bipolar Illness in the Primary Care Office.

Authors:  Jay A Brieler; Elizabeth Keegan-Garrett
Journal:  Mo Med       Date:  2022 May-Jun

2.  Designing the minimum data set of bipolar disorder: A basis for introducing the effective factors in managing, controlling, and monitoring the bipolar disorder.

Authors:  Khadijeh Moulaei; Kambiz Bahaadinbeigy; Shahrzad Mazhari
Journal:  J Educ Health Promot       Date:  2022-06-11

3.  TNF-α and its soluble receptors mediate the relationship between prior severe mood episodes and cognitive dysfunction in euthymic bipolar disorder.

Authors:  C E Millett; J Harder; J J Locascio; M Shanahan; G Santone; R N Fichorova; A Corrigan; C Baecher-Allan; K E Burdick
Journal:  Brain Behav Immun       Date:  2020-04-06       Impact factor: 7.217

4.  Akt-mTOR hypoactivity in bipolar disorder gives rise to cognitive impairments associated with altered neuronal structure and function.

Authors:  Amanda M Vanderplow; Andrew L Eagle; Bailey A Kermath; Kathryn J Bjornson; Alfred J Robison; Michael E Cahill
Journal:  Neuron       Date:  2021-03-24       Impact factor: 17.173

5.  Perceived helpfulness of bipolar disorder treatment: Findings from the World Health Organization World Mental Health Surveys.

Authors:  Andrew A Nierenberg; Meredith G Harris; Alan E Kazdin; Victor Puac-Polanco; Nancy Sampson; Daniel V Vigo; Wai Tat Chiu; Hannah N Ziobrowski; Jordi Alonso; Yasmin Altwaijri; Guilherme Borges; Brendan Bunting; José Miguel Caldas-de-Almeida; Josep Maria Haro; Chi-Yi Hu; Andrzej Kiejna; Sing Lee; John J McGrath; Fernando Navarro-Mateu; José Posada-Villa; Kate M Scott; Juan C Stagnaro; Maria C Viana; Ronald C Kessler
Journal:  Bipolar Disord       Date:  2021-03-28       Impact factor: 5.345

6.  Maladaptive personality traits and the course of suicidal ideation in young adults with bipolar disorder: Cross-sectional and prospective approaches.

Authors:  Anastacia Y Kudinova; Heather A MacPherson; Katharine Musella; Elana Schettini; Anna C Gilbert; Gracie A Jenkins; Lee Anna Clark; Daniel P Dickstein
Journal:  Suicide Life Threat Behav       Date:  2020-08-31

Review 7.  Therapeutic approaches employing natural compounds and derivatives for treating bipolar disorder: emphasis on experimental models of the manic phase.

Authors:  Vânia Machado Recart; Luiza Spohr; Mayara Sandrielly Pereira Soares; Karina Pereira Luduvico; Francieli Moro Stefanello; Roselia Maria Spanevello
Journal:  Metab Brain Dis       Date:  2021-07-15       Impact factor: 3.584

8.  Postpartum Psychosis after Traumatic Cesarean Delivery.

Authors:  Evangelia Antoniou; Eirini Orovou; Kassiani Politou; Alexandros Papatrechas; Ermioni Palaska; Angeliki Sarella; Maria Dagla
Journal:  Healthcare (Basel)       Date:  2021-05-16

Review 9.  A Comprehensive Review on the Role of Non-Coding RNAs in the Pathophysiology of Bipolar Disorder.

Authors:  Soudeh Ghafouri-Fard; Elham Badrlou; Mohammad Taheri; Kenneth M Dürsteler; Annette Beatrix Brühl; Dena Sadeghi-Bahmani; Serge Brand
Journal:  Int J Mol Sci       Date:  2021-05-13       Impact factor: 5.923

Review 10.  Hyperprolactinemia, Clinical Considerations, and Infertility in Women on Antipsychotic Medications.

Authors:  Amber N Edinoff; Nancy S Silverblatt; Hayley E Vervaeke; Cassidy C Horton; Eden Girma; Alan D Kaye; Adam Kaye; Jessica S Kaye; Andrew J Garcia; Elisa E Neuchat; Treniece N Eubanks; Giustino Varrassi; Omar Viswanath; Ivan Urits
Journal:  Psychopharmacol Bull       Date:  2021-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.